Chlorine in PDB 4czg: C. Crescentus Mreb, Single Filament, Adp, A22 Inhibitor
Protein crystallography data
The structure of C. Crescentus Mreb, Single Filament, Adp, A22 Inhibitor, PDB code: 4czg
was solved by
J.Lowe,
F.Van Den Ent,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
20.397 /
1.50
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
50.674,
73.678,
54.233,
90.00,
102.39,
90.00
|
R / Rfree (%)
|
16.38 /
21.77
|
Other elements in 4czg:
The structure of C. Crescentus Mreb, Single Filament, Adp, A22 Inhibitor also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the C. Crescentus Mreb, Single Filament, Adp, A22 Inhibitor
(pdb code 4czg). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the
C. Crescentus Mreb, Single Filament, Adp, A22 Inhibitor, PDB code: 4czg:
Jump to Chlorine binding site number:
1;
2;
Chlorine binding site 1 out
of 2 in 4czg
Go back to
Chlorine Binding Sites List in 4czg
Chlorine binding site 1 out
of 2 in the C. Crescentus Mreb, Single Filament, Adp, A22 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of C. Crescentus Mreb, Single Filament, Adp, A22 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1335
b:22.7
occ:0.70
|
CL1
|
A:QH31335
|
0.0
|
22.7
|
0.7
|
C02
|
A:QH31335
|
1.7
|
24.8
|
0.7
|
C12
|
A:QH31335
|
2.7
|
21.8
|
0.7
|
C03
|
A:QH31335
|
2.7
|
21.4
|
0.7
|
HG11
|
A:VAL111
|
2.7
|
40.9
|
1.0
|
H03
|
A:QH31335
|
2.8
|
25.5
|
0.7
|
HB2
|
A:ALA115
|
2.9
|
26.5
|
1.0
|
HG13
|
A:ILE123
|
3.0
|
32.3
|
1.0
|
CL2
|
A:QH31335
|
3.1
|
29.9
|
0.7
|
HB3
|
A:GLU119
|
3.3
|
22.1
|
1.0
|
HB3
|
A:ALA115
|
3.3
|
26.5
|
1.0
|
HA
|
A:ARG120
|
3.4
|
19.8
|
1.0
|
CB
|
A:ALA115
|
3.5
|
22.2
|
1.0
|
HG12
|
A:ILE123
|
3.6
|
32.3
|
1.0
|
CG1
|
A:VAL111
|
3.6
|
34.2
|
1.0
|
HG23
|
A:VAL111
|
3.7
|
49.3
|
1.0
|
HG12
|
A:VAL111
|
3.7
|
40.9
|
1.0
|
CG1
|
A:ILE123
|
3.7
|
27.0
|
1.0
|
HG3
|
A:ARG120
|
3.8
|
25.6
|
1.0
|
HD2
|
A:PRO112
|
3.8
|
22.2
|
1.0
|
HB1
|
A:ALA115
|
3.8
|
26.5
|
1.0
|
O
|
A:GLU119
|
3.9
|
17.0
|
1.0
|
HB2
|
A:GLU119
|
3.9
|
22.1
|
1.0
|
C
|
A:GLU119
|
3.9
|
14.5
|
1.0
|
C11
|
A:QH31335
|
4.0
|
19.4
|
0.7
|
CB
|
A:GLU119
|
4.0
|
18.5
|
1.0
|
C04
|
A:QH31335
|
4.0
|
17.6
|
0.7
|
N
|
A:ARG120
|
4.0
|
18.8
|
1.0
|
HG2
|
A:ARG120
|
4.0
|
25.6
|
1.0
|
HD12
|
A:ILE79
|
4.1
|
27.2
|
1.0
|
HB
|
A:ILE123
|
4.1
|
28.0
|
1.0
|
CA
|
A:ARG120
|
4.2
|
16.6
|
1.0
|
HG13
|
A:VAL111
|
4.2
|
40.9
|
1.0
|
CG2
|
A:VAL111
|
4.3
|
41.2
|
1.0
|
H
|
A:ARG120
|
4.3
|
22.4
|
1.0
|
CG
|
A:ARG120
|
4.3
|
21.5
|
1.0
|
HA
|
A:VAL111
|
4.3
|
23.1
|
1.0
|
HG22
|
A:VAL111
|
4.4
|
49.3
|
1.0
|
CB
|
A:VAL111
|
4.5
|
26.7
|
1.0
|
C05
|
A:QH31335
|
4.5
|
20.8
|
0.7
|
CB
|
A:ILE123
|
4.5
|
23.4
|
1.0
|
CA
|
A:GLU119
|
4.6
|
17.6
|
1.0
|
HG22
|
A:ILE123
|
4.6
|
28.6
|
1.0
|
H11
|
A:QH31335
|
4.7
|
23.1
|
0.7
|
H04
|
A:QH31335
|
4.8
|
21.0
|
0.7
|
HD12
|
A:ILE123
|
4.8
|
50.1
|
1.0
|
CD
|
A:PRO112
|
4.8
|
18.6
|
1.0
|
CA
|
A:ALA115
|
4.8
|
25.0
|
1.0
|
HA
|
A:ALA115
|
4.8
|
29.8
|
1.0
|
CB
|
A:ARG120
|
4.9
|
21.6
|
1.0
|
CD1
|
A:ILE123
|
4.9
|
41.9
|
1.0
|
CD1
|
A:ILE79
|
4.9
|
22.7
|
1.0
|
HG13
|
A:ILE79
|
4.9
|
30.4
|
1.0
|
CA
|
A:VAL111
|
5.0
|
19.4
|
1.0
|
HD13
|
A:ILE79
|
5.0
|
27.2
|
1.0
|
HG2
|
A:PRO112
|
5.0
|
31.0
|
1.0
|
|
Chlorine binding site 2 out
of 2 in 4czg
Go back to
Chlorine Binding Sites List in 4czg
Chlorine binding site 2 out
of 2 in the C. Crescentus Mreb, Single Filament, Adp, A22 Inhibitor
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of C. Crescentus Mreb, Single Filament, Adp, A22 Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl1335
b:29.9
occ:0.70
|
CL2
|
A:QH31335
|
0.0
|
29.9
|
0.7
|
C12
|
A:QH31335
|
1.7
|
21.8
|
0.7
|
C11
|
A:QH31335
|
2.7
|
19.4
|
0.7
|
C02
|
A:QH31335
|
2.7
|
24.8
|
0.7
|
H11
|
A:QH31335
|
2.8
|
23.1
|
0.7
|
HG13
|
A:ILE123
|
2.9
|
32.3
|
1.0
|
HG23
|
A:VAL111
|
3.0
|
49.3
|
1.0
|
CL1
|
A:QH31335
|
3.1
|
22.7
|
0.7
|
O
|
A:CYS110
|
3.2
|
23.0
|
1.0
|
HG13
|
A:VAL109
|
3.3
|
25.4
|
1.0
|
HG22
|
A:ILE123
|
3.3
|
28.6
|
1.0
|
HA
|
A:VAL111
|
3.3
|
23.1
|
1.0
|
HG12
|
A:VAL109
|
3.4
|
25.4
|
1.0
|
HD21
|
A:LEU17
|
3.4
|
41.8
|
1.0
|
HB3
|
A:LEU17
|
3.6
|
25.9
|
1.0
|
HD2
|
A:PRO112
|
3.7
|
22.2
|
1.0
|
CG1
|
A:VAL109
|
3.8
|
21.3
|
1.0
|
HG11
|
A:VAL111
|
3.8
|
40.9
|
1.0
|
CG1
|
A:ILE123
|
3.9
|
27.0
|
1.0
|
C05
|
A:QH31335
|
4.0
|
20.8
|
0.7
|
CG2
|
A:VAL111
|
4.0
|
41.2
|
1.0
|
C03
|
A:QH31335
|
4.0
|
21.4
|
0.7
|
HD23
|
A:LEU17
|
4.1
|
41.8
|
1.0
|
CG2
|
A:ILE123
|
4.2
|
23.9
|
1.0
|
HD13
|
A:ILE123
|
4.2
|
50.1
|
1.0
|
CD2
|
A:LEU17
|
4.2
|
34.9
|
1.0
|
CA
|
A:VAL111
|
4.2
|
19.4
|
1.0
|
C
|
A:CYS110
|
4.2
|
19.6
|
1.0
|
HD3
|
A:PRO112
|
4.2
|
22.2
|
1.0
|
HB2
|
A:LEU17
|
4.3
|
25.9
|
1.0
|
HG11
|
A:VAL109
|
4.3
|
25.4
|
1.0
|
CB
|
A:LEU17
|
4.3
|
21.7
|
1.0
|
HG21
|
A:VAL111
|
4.4
|
49.3
|
1.0
|
CD
|
A:PRO112
|
4.4
|
18.6
|
1.0
|
O
|
A:HOH2016
|
4.4
|
22.7
|
1.0
|
HD12
|
A:ILE123
|
4.4
|
50.1
|
1.0
|
CD1
|
A:ILE123
|
4.4
|
41.9
|
1.0
|
HG12
|
A:ILE123
|
4.4
|
32.3
|
1.0
|
HG21
|
A:ILE123
|
4.5
|
28.6
|
1.0
|
CB
|
A:ILE123
|
4.5
|
23.4
|
1.0
|
CB
|
A:VAL111
|
4.5
|
26.7
|
1.0
|
C04
|
A:QH31335
|
4.5
|
17.6
|
0.7
|
H102
|
A:QH31335
|
4.5
|
26.0
|
0.7
|
HB
|
A:ILE123
|
4.5
|
28.0
|
1.0
|
HG22
|
A:VAL111
|
4.5
|
49.3
|
1.0
|
CG1
|
A:VAL111
|
4.6
|
34.2
|
1.0
|
N
|
A:VAL111
|
4.7
|
17.2
|
1.0
|
H03
|
A:QH31335
|
4.8
|
25.5
|
0.7
|
HB
|
A:VAL109
|
4.8
|
21.2
|
1.0
|
CG
|
A:LEU17
|
4.9
|
29.4
|
1.0
|
HG23
|
A:ILE123
|
4.9
|
28.6
|
1.0
|
H061
|
A:QH31335
|
4.9
|
25.4
|
0.7
|
HD22
|
A:LEU17
|
4.9
|
41.8
|
1.0
|
CB
|
A:VAL109
|
4.9
|
17.8
|
1.0
|
HD23
|
A:LEU137
|
5.0
|
29.9
|
1.0
|
|
Reference:
F.Van Den Ent,
T.Izore,
T.A.Bharat,
C.M.Johnson,
J.Lowe.
Bacterial Actin Mreb Forms Antiparallel Double Filaments. Elife V. 3 02634 2014.
ISSN: ISSN 2050-084X
PubMed: 24843005
DOI: 10.7554/ELIFE.02634
Page generated: Sun Jul 21 11:37:00 2024
|